Sathish Dyawanapelly

Affiliations: 
Institute of Chemical Technology, Mumbai 
Area:
Drug Delivery, Nanomedicines, Pharmaceutics, Biomaterials
Google:
"Sathish Dyawanapelly"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Attar ES, Chaudhari VH, Deokar CG, et al. (2023) Nano Drug Delivery Strategies for an Oral Bioenhanced Quercetin Formulation. European Journal of Drug Metabolism and Pharmacokinetics
Patil A, Dyawanapelly S, Dandekar P, et al. (2020) Fabrication and Characterization of Non-spherical Polymeric Particles Journal of Pharmaceutical Innovation. 1-12
Atale SS, Dyawanapelly S, Jagtap DD, et al. (2018) Understanding the nano-bio interactions using real-time surface plasmon resonance tool. International Journal of Biological Macromolecules
Dyawanapelly S, Mehrotra P, Ghosh G, et al. (2018) How the surface functionalized nanoparticles affect conformation and activity of proteins: Exploring through protein-nanoparticle interactions. Bioorganic Chemistry. 82: 17-25
Dyawanapelly S, Jagtap DD, Dandekar P, et al. (2017) Assessing safety and protein interactions of surface-modified iron oxide nanoparticles for potential use in biomedical areas. Colloids and Surfaces. B, Biointerfaces. 154: 408-420
Dyawanapelly S, Kumar A, Chourasia MK. (2017) Lessons Learned from Gemcitabine: Impact of Therapeutic Carrier Systems and Gemcitabine's Drug Conjugates on Cancer Therapy. Critical Reviews in Therapeutic Drug Carrier Systems. 34: 63-96
Dyawanapelly S, Koli U, Dharamdasani V, et al. (2016) Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Drug Delivery and Translational Research
Dyawanapelly S, Junnuthula VR, Singh A. (2015) The Holy Grail of Polymer Therapeutics for Cancer Therapy: An Overview on the Pharmacokinetics and Bio Distribution. Current Drug Metabolism. 16: 522-37
See more...